This retrospective study was approved by the institutional review boards of eight hospitals (Kobe University Hospital, St. Luke's International Hospital, Nishinomiya Watanabe Hospital, Kobe City Medical Center General Hospital, Kobe City Nishi-Kobe Medical Center, Hyogo Prefectural Kakogawa Medical Center, Kita Harima Medical Center, and Hyogo Prefectural Awaji Medical Center); the requirement for acquiring informed consent was waived by the institutional review boards of these eight hospitals owing to the retrospective nature of the study. This study complied with the Declaration of Helsinki and Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan (https://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf).
The CXR datasets used for developing and evaluating our DL model contain CXRs for the following three categories: normal CXR (NORMAL), non-COVID-19 pneumonia CXR (PNEUMONIA), and COVID-19 pneumonia CXR (COVID). Our DL model was developed using two public (COVIDx and COVIDBIMCV) and one private (COVIDprivate) datasets. One public dataset (COVIDx) was built to accelerate the development of highly accurate and practical deep learning model for detecting COVID-19 cases (https://github.com/lindawangg/COVID-Net/blob/master/docs/COVIDx.md)15. The other public dataset (COVIDBIMCV) was constructed from two public datasets: the PadChest dataset (https://github.com/auriml/Rx-thorax-automatic-captioning)16 and BIMCV-COVID19+dataset (https://github.com/BIMCV-CSUSP/BIMCV-COVID-19)17. COVIDprivate was based on the dataset collected from six hospitals previously, and the two public datasets (COVIDx and COVIDBIMCV) were the same as those in previous studies18,19. The details of these datasets are described in the Supplementary material. Compared with the previous study, CXRs were added for COVIDprivate in the current study. The additional CXRs included 37, 7, and 31 cases of NORMAL, PNEUMONIA, and COVID, respectively. COVIDprivate contained 530 CXRs (176 NORMAL, 146 PNEUMONIA, and 208 COVID).
In addition to COVIDprivate, CXRs were collected from two other medical institutions. In total, 168 CXRs (80 NORMAL, 37 PNEUMONIA, and 51 COVID) collected from one medical institution (Hospital A) were used for the internal validation of the DL model (as a part of validation set) and for radiologists reading practice conducted before the observer study. Moreover, as unseen test set, 180 CXR cases (60 NORMAL, 60 PNEUMONIA, and 60 COVID) collected from another medical institution (Hospital B) were used for the external validation of the DL model and observer study of radiologists.
In the Hospital B, COVID was limited to those diagnosed with COVID-19 pneumonia using RT-PCR, and CXR was obtained after symptom onset. The time of COVID-19 diagnosis was between January 24, 2020, and May 5, 2020. PNEUMONIA was defined as patients clinically diagnosed with bacterial pneumonia that improved with appropriate treatment. Patients who showed no pneumonia on CT or had lung metastasis of malignancy and acute exacerbation of interstitial pneumonia were excluded from PNEUMONIA. NORMAL was defined as the absence of abnormalities in the lung, mediastinum, thoracic cavity, or chest wall on CXR and CT. NORMAL and PNEUMONIA were limited to cases before the summer of 2019 (before the COVID-19 pandemic). The details of the unseen test set collected from the Hospital B are described in the Supplementary material. The inclusion criteria of CXRs in the COVIDprivate and the Hospital A were the same as the previous study19.
Table 1 lists the details of each CXR dataset. The 180 cases (as the unseen test set) used for the external validation and reading sessions were adults aged 20years or older. In the 180 cases, NORMAL included 39 men and 21 women aged 58.127.9years. PNEUMONIA included 43 men and 17 women aged 76.220.8years. The COVID group included 46 men and 14 women aged 53.438.6years.
Our EfficientNet-based DL model was constructed in the same manner as described in previous papers18,19. Figure1 shows a schematic of the construction of the DL model. There are two major differences in the DL model construction between the present study and previous studies; one is that the 168 CXRs collected from Hospital A were used for internal validation as a part of the validation set, and the other is that the 180 CXRs collected from Hospital B were used for external validation as the unseen test set. The DL model development set included two public datasets, COVIDprivate, and 168 CXRs collected from Hospital A. Five different random divisions of the training and validation sets were created from the development set. In the division, 300, 300, and 90 images were randomly selected as the validation set from COVIDx, COVIDBIMCV, and COVIDprivate, respectively. The remaining images of COVIDx, COVIDBIMCV, and COVIDprivate were used as the train set. In addition, all the 168 CXRs collected from Hospital A were used for the validation set. Model training and internal validation of diagnostic performance were performed for the training set and validation set, respectively. The training of our DL model is also described in the Supplementary material.
Schematic illustration of dataset splitting and model training for our DL model. Abbreviation: DL, deep learning; COVIDx, public dataset used for COVID-Net; COVIDBIMCV, public dataset obtained from the PadChest and BIMCV-COVID19+datasets; COVIDprivate, private dataset collected from six hospitals; Hospital A, dataset collected for internal validation and radiologists practice before the observer study; Hospital B, dataset collected for external validation.
The inference results of the DL model were calculated using an ensemble of five trained models. For the 180 CXRs of the external validation, an average of the probabilities obtained from the five trained models was calculated as the inference results of the DL model to evaluate the diagnostic performance of the DL model and to provide supporting information for radiologists during the observer study.
The DL model calculated the probability of NORMAL, PNEUMONIA, or COVID for each CXR, with a total of 100%. We also created images using Grad-CAM and Grad-CAM++as explainable artificial intelligence, which visualized the reasoning for the diagnosis of the DL model20,21. Grad-CAM and Grad-CAM++images were used for the observer study. Minmax normalization with a linear transformation was performed on the original Grad-CAM and Grad-CAM++images.
Eight radiologists (with 520years of experience in diagnostic radiology) performed the observer study at two medical facilities. For the 180 CXRs collected from Hospital B, each radiologist performed two reading sessions over a period of more than 1month. One reading session was performed with reference to CXRs only, and the other was performed with reference to both CXRs and the results of the DL model. The order of the two sessions was randomly selected to reduce bias. The eight radiologists scored the probabilities of NORMAL, PNEUMONIA, and COVID on a 100% scale. In the reading session with the DL model, the radiologists referred to the probabilities of NORMAL, PNEUMONIA, and COVID calculated using the DL model. If there was any uncertainty regarding the probabilities of the DL model, the results of Grad-CAM and Grad-CAM++were available. Images of the 168 CXRs collected from Hospital A were also processed with Grad-CAM and Grad-CAM++, and the diagnosis of the DL model and images of Grad-CAM and Grad-CAM++of the 168 CXRs were presented to the radiologists for practice sessions before each reading session. Eight radiologists were taught how to interpret the Grad-CAM and Grad-CAM++images before the observer study. There was no time limit for reading and practice sessions. Prior to the reading sessions, only the approximate frequencies of the three categories were presented to the radiologists and no other clinical information was provided. Our novelties in this study were to investigate whether radiologists changed their diagnosis by referring to our DL model of CXR and whether the diagnostic performance of radiologists was significantly improved.
After the observer study, one senior radiologist visually evaluated the 180 Grad-CAM++images in the test set. The visual evaluation of the Grad-CAM++images was performed on the images that were accurately diagnosed by the DL. The radiologist visually examined the CXR and Grad-CAM++images and determined whether the Grad-CAM++images were typical or understandable. The typical Grad-CAM++images were described in Supplementary material. If abnormal findings on CXR images were highlighted on Grad-CAM++images, the cases were considered understandable by the radiologist. In addition, for COVID, the radiologist counted the number of Grad-CAM++images with highlighted regions outside the lung area.
We evaluated the diagnostic performance of the DL model alone and compared the results between reading sessions with and without the DL model. The evaluation metrics were accuracy, sensitivity, specificity, and area under the curve (AUC) in the receiver operating characteristics. Because three-category classification was performed, these metrics were calculated class-wise (one-vs-rest), except for accuracy. For the AUC, multi-reader multi-case statistical analysis was used to statistically analyze the results of the eight radiologists. MRMCaov was used for the statistical analyses22. Although MRMCaov is a statistical method designed for binary classification of two categories, this study was designed to diagnose three categories: NORMAL, PNEUMONIA, and COVID. Therefore, the three-category classification was divided into three binary classifications (one-vs-rest): (1) NORMAL versus PNEUMONIA or COVID, (2) PNEUMONIA versus NORMAL or COVID, and (3) COVID versus NORMAL or PNEUMONIA. We then compared the class-wise AUC of the eight radiologists between reading sessions with and without the DL model. The difference in the AUC was statistically tested using MRMCaov. Because it was necessary to integrate the results from the eight radiologists, the class-wise MRMCaov was used in the present study. To control the family-wise error rate, Bonferroni correction was used; a p value less than 0.01666 was considered statistically significant. R (version 4.1.2) was used for the statistical analysis.
Read more:
Computer-aided diagnosis of chest X-ray for COVID-19 diagnosis in ... - Nature.com
- Biohackers Are on a Secret Hunt for the Coronavirus Vaccine - Reason [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Can synthetic biology protect us from coronavirus? And the next one? - Big Think [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- When will there be a coronavirus vaccine and who will get it first? - Yahoo News [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- These nine companies are working on coronavirus treatments or vaccines heres where things stand - MarketWatch [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus Vaccine At Least a Year Away, But Treatment Could Be Here in Months - Newsweek [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus Drug and Vaccine Studies Are Recruiting Their First Volunteers - TIME [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Brexit means coronavirus vaccine will be slower to reach the UK - The Guardian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- First patient injected in trial of coronavirus vaccine - WCVB Boston [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- A coronavirus vaccine is in the making But you may have to check your pockets first - Duke Chronicle [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus vaccines and treatment: Everything you need to know - CNET [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus outbreak: How much testing should we do, and where are we on developing a vaccine? - Economic Times [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Coronavirus Vaccines Precision Vaccinations [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- How Long Will It Take to Develop a Vaccine for Coronavirus? [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- California lab says it discovered coronavirus vaccine in 3 hours [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Coronavirus outbreak in Wuhan, China: Vaccine may be ready in ... [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Everything You Need to Know About Canine Coronavirus Vaccine [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- CSU Researchers Are Working Full-Bore On The Mysteries Of Coronavirus And A Vaccine - Colorado Public Radio [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- How soon will we have a coronavirus vaccine? The race against covid-19 - New Scientist [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Coronavirus trial vaccine participant says he wants to help the world - CNN [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Daily briefing: The five questions that scientists hunting a coronavirus vaccine must answer - Nature.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Baltimore scientists to work on third experimental coronavirus vaccine - Baltimore Sun [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- The coronavirus could kill millions of Americans: 'Do the math,' immunization specialist says - CNBC [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- We're still in the early days of coronavirus vaccine research - Axios [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Inoculating the Coronavirus Vaccine Against the Profit Pandemic - The New Republic [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Wanted: People Willing to Get Sick to Find Coronavirus Vaccine - The Wall Street Journal [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus vaccine trial, Mars rover delay and a boost for UK science - Nature.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Thousands of scientists are racing to find a vaccine for coronavirus. 41 possibilities are in the works. - The Californian [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- 'I Wanted To Do Something,' Says Mother Of 2 Who Is First To Test Coronavirus Vaccine - NPR [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Vaccine Trials To Fight Coronavirus Offer Hope, Could Be Harbinger Of New Technology - Outlook India [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Image of COVID-19 test kit shared as newly developed 'coronavirus vaccine' by Roche - Alt News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- A coronavirus vaccine is the only thing that can make life 'perfectly normal' again, former FDA commissioner says - The Week [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Johnson & Johnson CEO on potential coronavirus vaccine: 'I think we'll have important data by the end of the year' - Fox News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- As the First Coronavirus Vaccine Human Trials Begin, Manufacturer Is Already Preparing to Scale Production to Millions - TIME [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- A coronavirus vaccine is the only thing that can make life 'perfectly normal' again, former FDA commissioner says - Yahoo News [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- This Vaccine Could Save Health Care Workers From the Coronavirus - Foreign Policy [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Coronavirus vaccine must be affordable and accessible - The Conversation CA [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Over 100 drugs are in testing in the race to treat coronavirus - Axios [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- This is when the first coronavirus drugs might actually be available - BGR [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Another Day, Another Meme to Debunk: Vaccines for the Bovine Coronavirus Will Not Cure COVID-19 - Mother Jones [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- A Coronavirus Vaccine Could Be the First That Outwits Nature - Singularity Hub [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Coronavirus treatment other than vaccines may be available soon - The Jerusalem Post [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Coronavirus: Vaccine hopes given boost as researcher says virus not mutating - The Independent [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Coronavirus Vaccine Is Critical, The Infection Could Become Seasonal, Researchers Warn - NDTV News [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- A coronavirus vaccine from Virginia? These researchers are working on it. - The Virginian-Pilot - The Virginian-Pilot [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Scientists, under pressure, try to balance speed and safety on coronavirus vaccine research - NBCNews.com [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Should scientists infect healthy people with the coronavirus to test vaccines? - Nature.com [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Coronavirus Vaccines May Not Work for the Elderlyand This Lab Aims to Change That - Scientific American [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Vaccine Development Is Risky Business. Biotechs Are Tackling The Coronavirus, Anyway - WBUR [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- Coronavirus vaccine: how soon will we have one? - World Economic Forum [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- USC Working on Coronavirus Vaccine, Researchers Announce - NBC Southern California [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- Tracking the development of coronavirus treatments - NBC News [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- In the fight against coronavirus, antivirals are as important as a vaccine. Here's where the science is up to - The Conversation AU [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- Johnson & Johnson Says It Could Have Coronavirus Vaccine Ready by Early 2021 - The Daily Beast [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- Coronavirus: when will the vaccine be ready? - AS South Africa [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- A Coronavirus Vaccine Is Coming, And It Will Work - City Journal [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- With record-setting speed, vaccinemakers take their first shots at the new coronavirus - Science Magazine [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- CDC: Coronavirus Vaccine Will Be Ready for Refusal By Anti-Vaxxers By 2021 - MedPage Today [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- The race to find a coronavirus treatment has one major obstacle: big pharma - The Guardian [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- Why A Coronavirus Vaccine May Be Years Away - The National Interest [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- The race is on for coronavirus vaccines and treatments: current R&D status - The Pharma Letter [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- Tests of potential coronavirus vaccine spur growth of virus-fighting antibodies - USA TODAY [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- A 100-yr-old vaccine is being tested against the new coronavirus. Can it work? - Economic Times [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Coronavirus Live Updates: Boris Johnson Moved to Intensive Care and the U.S. Death Toll Surpasses 10,000 - The New York Times [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- When will a coronavirus shot be ready? A look at the vaccine race. - WRAL.com [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Hulk Hogan on coronavirus: Maybe we dont need a vaccine - Tampa Bay Times [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- White House advisor Fauci says coronavirus vaccine trial is on target and will be 'ultimate game changer' - CNBC [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Coronavirus vaccine will take time, so researchers are hunting for and finding promising new COVID-19 tre - OregonLive [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Chester County to begin testing for coronavirus antibodies; British prime minister moved to intensive care - The Philadelphia Inquirer [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- MAP: Where coronavirus treatments and vaccines are being tested on patients in the US - Business Insider - Business Insider [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Coronavirus pandemic: Why it takes so long to make a vaccine - Business Today [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- A vaccine for coronavirus is the goal, but what does it take to get there? - ABC News [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Trump says there's light at the end of the tunnel with coronavirus vaccine and treatment research - CNBC [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Russia Ready to Start Testing Coronavirus Vaccines on Humans in June - The Moscow Times [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Why a coronavirus vaccine takes over a year to produce and why that is incredibly fast - World Economic Forum [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Pandemic expert calls for manufacturing coronavirus vaccines before they're proven to work - The Week [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- More Coronavirus Vaccine Efforts Move Toward Human Trials - The New York Times [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- A coronavirus vaccine is being developed in record time. But don't expect that technology to speed up flu vaccines yet. - USA TODAY [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- A New Front for Nationalism: The Global Battle Against a Virus - The New York Times [Last Updated On: April 10th, 2020] [Originally Added On: April 10th, 2020]
- Here's how your body gains immunity to coronavirus - The Guardian [Last Updated On: April 10th, 2020] [Originally Added On: April 10th, 2020]
- Pfizer aims to create coronavirus vaccine by end of 2020 - MLive.com [Last Updated On: April 10th, 2020] [Originally Added On: April 10th, 2020]